This transaction was executed in multiple trades at prices ranging from $25.50 to $25.81. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.
To receive a free e-mail notification whenever Natus Medical Incorporated makes a similar move, sign up!
Other recent filings from the company include the following:
Natus Medical: Use Of Non-Gaap Financial Measures - July 23, 2014